Literature DB >> 1898680

Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.

R C Becker1, J M Corrao, R Harrington, S P Ball, J M Gore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1898680     DOI： 10.1016/0002-8703(91)90986-r

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  4 in total

Review 1.  MYOCARDIAL REVASCULARIZATION.

Authors:  R S Rajan
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 2.  Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction.

Authors:  S Noble; D McTavish
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 3.  Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.

Authors:  L B Barradell; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

Review 4.  Alteplase. A reappraisal of its pharmacological properties and therapeutic use in acute myocardial infarction.

Authors:  J C Gillis; A J Wagstaff; K L Goa
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.